tirzepatide once weekly for the treatment of obesity journal club

tirzepatide once weekly for the treatment of obesity journal club VisualAbstract: Once-weekly significantly improves weight and glycemic control in patients with with and type 2 diabetes Steady coverage of obesity drugs

Name: tirzepatide once weekly for the treatment of obesity journal club VisualAbstract: Once-weekly significantly improves weight and glycemic control in patients with with and type 2 diabetes Steady coverage of obesity drugs
Brand: actil.am
SKU: 46981584664
Price: 22.44 USD
Availability: InStock
Rating: 4.0306 (22 reviews)

SKU: 46981584664

4.0

USD22.44 USD62.44

Pay in 4 interest-free payments of $5.61 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 14 - Aug 19

Description

For context, hair loss has been reported in post-marketing data and UK SmPCs for semaglutide 2.4 mg and tirzepatide, both of which share mechanistic similarities with retatrutide

Participants who took 2.4 mg of semaglutide weekly lost an average of 14.9% of their body weight over 68 weeks (about 16 months), compared to 2.4% in the placebo group

Always talk with your provider first

Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): A multicentre, randomised, double-blind, placebo-controlled phase 3 trial